Stimulation and inhibition of neoplastic cell growth by tumor promoter-treated macrophages.

[1]  R. Schultz,et al.  Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. , 1978, Science.

[2]  D. Rosenstreich,et al.  Phorbol myristic acetate stimulates LAF production by the macrophage cell line, P388D. , 1978, Cellular immunology.

[3]  H. Broxmeyer,et al.  Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. , 1978, Blood.

[4]  E. Unanue.  The Regulation of Lymphocyte Functions by the Macrophage , 1978, Immunological reviews.

[5]  A. Cheever.  Schistosomiasis and neoplasia. , 1978, Journal of the National Cancer Institute.

[6]  A. Hamburger,et al.  IMMUNOPROLIFERATION AND CANCER: A COMMON MACROPHAGE-DERIVED PROMOTER SUBSTANCE , 1978, The Lancet.

[7]  J. White,et al.  The effect of phorbol myristate acetate on the metabolism and ultrastructure of human alveolar macrophages. , 1978, The American journal of pathology.

[8]  R. Evans,et al.  Macrophage requirement for growth of a murine fibrosarcoma. , 1978, British Journal of Cancer.

[9]  S. Leibovich.  Production of macrophage-dependent fibroblast-stimulating activity (M-FSA) by murine macrophages. Effects on BALBc 3T3 fibroblasts. , 1978, Experimental cell research.

[10]  R. Schultz,et al.  Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations. , 1978, Cancer research.

[11]  A. W. Murray,et al.  Tumor promotion and the induction of epidermal ornithine decarboxylase activity in mechanically stimulated mouse skin. , 1978, Cancer research.

[12]  E. Hecker,et al.  Inflammatory, tumor initiating and promoting activities of polycyclic aromatic hydrocarbons and diterpene esters in mouse skin as compared with their prostaglandin releasing potency in vitro. , 1978, Cancer letters.

[13]  U. Heine,et al.  Functional and morphologic characteristics of interferon-treated macrophages. , 1978, Cellular immunology.

[14]  P. Kincade,et al.  Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors , 1977, The Journal of experimental medicine.

[15]  J. Papamatheakis,et al.  Association of macrophage activation with antitumor activity by synthetic and biological agents. , 1977, Cancer research.

[16]  J. Papamatheakis,et al.  Interferon: an inducer of macrophage activation by polyanions. , 1977, Science.

[17]  J. Vassalli,et al.  Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate , 1977, Cell.

[18]  J. Papamatheakis,et al.  Macrophage involvement in the protective effect of pyran copolymer against the Madison lung carcinoma (M109). , 1977, Cancer research.

[19]  P. Alexander.  Innate resistance and specific immunity in host control of cancer. , 1977, Journal of medicine.

[20]  M. Potter,et al.  The requirement of an adherent cell substratum for the growth of developing plasmacytoma cells in vivo , 1976, The Journal of experimental medicine.

[21]  M. Kripke,et al.  Brief Communication: Accelerated Development of Benzo [a] pyrene-Induced Skin Tumors in Mice Treated With Pyran Copolymer , 1974 .

[22]  A. Raick.  Cell proliferation and promoting action in skin carcinogenesis. , 1974, Cancer research.

[23]  Y. Namba,et al.  Immunocytology of cultured IgM-forming cells of mouse. II. Purification of phagocytic cell factor and its role in antibody formation. , 1974, Cellular immunology.

[24]  R. Evans.  MACROPHAGES IN SYNGENEIC ANIMAL TUMOURS , 1972, Transplantation.

[25]  J. Pumphrey,et al.  Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment. , 1972, Journal of the National Cancer Institute.